STAQ Pharma recently raised about $45 Million of Series C venture funding to build a $70 million facility on the west side of Columbus, which will add 300 jobs to the area. Its 503B Outsourcing Facility will produce compounded medications under the Current Good Manufacturing Process (cGMP) quality system, a Federal Drug Administration standard. CEO Joe Bagan sat down with the Dealmakers Podcast to discuss the capital raises and the new, much larger facility being built in Columbus.
